VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…
VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…
Annual Drug Patent Expirations for VESICARE Vesicare is a drug marketed by Astellas and is included in one NDA. It is available from five suppliers. There is one patent protecting…
The post New patent expiration for Astellas drug VESICARE appeared firs…
VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…
Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post Patent delisted for Allergan drug SANCTURA XR appeared first o…
Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post Patent delisted for Allergan drug SANCTURA XR appeared first o…
Annual Drug Patent Expirations for FIASP Fiasp is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents protecting…
The post Patent delisted for NOVO drug FIASP appeared first on DrugPatentWat…
Annual Drug Patent Expirations for FIASP+FLEXTOUCH Fiasp Flextouch is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post Patent delisted for NOVO drug FIASP FLEXTOUCH appeared fir…
Annual Drug Patent Expirations for EXUBERA Exubera is a drug marketed by Pfizer and is included in one NDA. There are three patents protecting this drug. This drug has three…
The post New patent expiration for Pfizer drug EXUBERA appeared first on Drug…
Annual Drug Patent Expirations for EPANOVA Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are nine patents protecting this drug. This drug has…
The post New patent expiration for Astrazeneca Pharms drug EPANOVA appea…